Remifentanil vs. Nicardipine for Controlled Hypotension in Elective Nasal Surgery

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSaglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital

About this trial

This study compares remifentanil infusion versus nicardipine infusion for controlled hypotension during elective nasal surgery. Both agents are standard clinical methods. The study evaluates hemodynamic stability, surgical field quality (Fromme-Boezaart score), tissue perfusion, intraoperative blood loss, surgeon satisfaction, and perioperative adverse effects.

Eligibility criteria

Qualifiers

Age > 18 years

ASA physical status I-II

Scheduled for elective nasal surgery

No known serious cardiovascular, respiratory, renal, or hepatic disease

Disqualifiers

Age < 18 years

ASA III or above

Known serious cardiovascular, respiratory, renal, or hepatic disease

Known allergy to remifentanil or nicardipine

Trial design

Treatments tested in this trial

  • Nicardipine
  • Remifentanil

Treatment groups

44 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators